Industry News

Altair Nanotechnologies Announces New Board Member Appointment

Published on 2004-07-13. Author : SpecialChem

RENO, NV -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI), a company engaged in developing performance materials and life science products using its metal oxide pigment and nanomaterials technology platforms, today announced the appointment of Dr. Michel Bazinet to its board of directors.

"We are pleased to announce the appointment of Dr. Michel Bazinet to our board of directors," said Altair Board Chairman Jon Bengston. "Dr. Bazinet's extensive medical industry expertise, coupled with his prior board of director and biotech industry experience, will add further depth to our board, especially useful for our Life Sciences Division."

"Altair is one of the nanotechnology leaders poised to make a tremendous impact on the biotech industry," said Dr. Bazinet. "I am honored to be appointed to its board, and am eager to provide strategic guidance and leverage industry contacts to further Altair's mission."

About Dr. Michel Bazinet

Dr. Bazinet brings extensive medical, biotech and health sciences experience to Altair. Dr. Bazinet is Chairman & CEO of privately held Replicor, Inc. which develop new antiviral and anticancer therapies. Prior to his involvment with Replicor, Dr. Bazinet was the founder and medical director of Mediconsult, a healthcare knowledge company. Mediconsult completed its initial public offering in 1999 and was ultimately acquired by The Cybear Group in 2001.

Dr. Bazinet, a board-certified urologist, received his MD from Sherbrooke University. He completed his residency at McGill University, Montreal, and has been a research fellow at Memorial Sloan-Kettering Cancer Center, New York. Dr. Bazinet, a former assistant professor of both urology and oncology at McGill University, is also an accomplished speaker, medical industry author and consultant.


Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a robust proprietary technology platform for making a wide variety of nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation.

Altair Nanotechnologies, Inc.®, Altair NanomaterialsTM, TiNano®, RenaZorbTM, NanoCheckTM, TiNano SpheresTM, No DefeatTM and the Hydrochloride Pigment ProcessTM are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

Source: Altair Nanotechnologies

The Chemicals Sales & Marketing Toolbox
Channel Alerts

Receive weekly digests on hot topics

Back to Top